Sprycel
Bristol-Myers Squibb manufactures prescription...
LEARN MORE »
Pharmaceutical Name Validation
A compelling brand is what everyone wants, but the road to get there requires a level of expertise that very few possess. Sophisticated research methodology is the backbone of the Addison Whitney process.
By thoroughly testing and evaluating brand name candidates, we reduce the potential for medication error by uncovering phonographic and orthographic issues that may compromise patient safety. But research alone means nothing without expert analysis. Examination of data is the foundation by which our brand recommendations are made – ensuring the development of safe brands and increasing the likelihood of regulatory success.
We retain a panel of medical professionals – including nurses, physicians and pharmacists – to help make the best possible recommendations to our clients.
LEARN MORE »
LEARN MORE »
Based on evolving FDA, EMA and Health Canada guidance, our research reflects the latest policies enforced by the world’s regulatory entities.
LEARN MORE »
LEARN MORE »
Our brand name submission documents adhere to the latest guidance issued by the FDA, EMA and Health Canada.
LEARN MORE »
LEARN MORE »
